Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide in infants with short bowel syndrome dependent on parenteral support
2017-003606-40Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Feb 2018; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2017-003606-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003606-40.